AGILE SCIENCES, INC.

Company Information

Company Name
AGILE SCIENCES, INC.
Address
1791 Varsity Dr.
RALEIGH, NC, 27606-2576
Phone
1 919-457-3308
URL
n/a
DUNS
828576202
Number of Employees
1
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,924,302.00
6
SBIR Phase II
$1,030,274.00
1
STTR Phase I
$1,178,162.00
4
STTR Phase II
$1,499,094.00
1

Award List

  1. Targeting Oral Biofilms with 2-Aminoimidazole/Triazole Conjugates

    Amount: $251,837.00

    DESCRIPTION (provided by applicant): Dental caries, or tooth decay, affects hundreds of millions of people each year, and is second only to the common cold in its prevalence world-wide. New therapeut ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Prevention of Bacterial Biofilms on CSF Shunts through the Incorporation of Novel

    Amount: $570,115.00

    DESCRIPTION (provided by applicant): This NIH SBIR project assesses the feasibility of applying a discovery made by the cofounders of Agile Sciences, Inc. to developing a more effective therapeutic st ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. STTR Phase I: Increasing the Efficiency of Membrane Filtration for Drinking Water Purification through the Incorporation of Novel Anti-Biofilm Small Molecules

    Amount: $149,999.00

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer Phase I Project tests the feasibility of applying Agile Scien ...

    STTR Phase I 2009 National Science Foundation
  4. SBIR Phase I: Preventing Biofilms on Indwelling Medical Devices with Novel Anti-Biofilm Small Molecules

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project describes a new approach for reducing infections associated with indwelling medical devices. Bacteria on medical devices are particularly ...

    SBIR Phase I 2011 National Science Foundation
  5. Development of Small Molecules to Combat Bacterial Biofilms

    Amount: $545,129.00

    DESCRIPTION (provided by applicant): Bacterial infections are responsible for an estimated 100,000 deaths in the United States each year, and despite the dire unmet medical need, few new treatment op ...

    SBIR Phase I 2011 Department of Health and Human Services
  6. Development of Novel Anti-Biofilm Compounds for Treating Chronic Wounds

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Chronic wounds that fail to respond to traditional therapeutic interventions afflict millions of people each year, and direct costs associated with treatin ...

    STTR Phase I 2011 Department of Health and Human Services
  7. Anti-biofilm agents for treating pulmonary infection in Cystic Fibrosis patients

    Amount: $428,163.00

    DESCRIPTION (provided by applicant): Cystic fibrosis (CF) is the most common life shortening inherited disorder amongst Caucasians, and Pseudomonas aeruginosa pulmonary infections are the leading caus ...

    STTR Phase I 2011 Department of Health and Human Services
  8. Targeting Oral Biofilms with 2-Aminoimidazole/Triazole Conjugates

    Amount: $1,030,274.00

    DESCRIPTION (provided by applicant): Dental caries is one of the most prevalent diseases in the U.S. with 85% of adults and the majority of children having been treated for at least one incidence. Wh ...

    SBIR Phase II 2012 Department of Health and Human Services
  9. SBIR Phase I: Enhancing the Bactericidal Activity of Copper: An Economically Viable Solution for Lowering Copper Usage Rates in Agriculture

    Amount: $150,000.00

    This Small Business Innovation Research Phase I project describes a cost-effective method for reducing the quantities of copper used for agricultural crop protection. Currently, millions of pounds of ...

    SBIR Phase I 2012 National Science Foundation
  10. Small Molecules to Enhance Bacterial Susceptibility to Antiseptics

    Amount: $257,221.00

    DESCRIPTION (provided by applicant): One-third of costs associated with hospital acquired infections (HAIs) are attributed to surgical site infections (SSIs), and SSIs result in a two-fold increase in ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government